Global skincare experts passionate about skin health for more than 165 years
Location: United States, New Jersey, Princeton
Employees: 51-200
Founded date: 1847
Investors 2
| Date | Name | Website |
| - | Aisling Ca... | aislingcap... |
| - | New Leaf V... | nlvpartner... |
Mentions in press and media 14
| Date | Title | Description |
| 27.09.2012 | Freedom Meditech secures $2M as it awaits approval of chronic disease detection device | Intended to be used by eye care professionals as part of routine eye exams, the test takes six seconds, produces immediate results and requires no preparation or blood draw. If everything goes smoothly with the approval process, the company... |
| 31.05.2012 | GSK’s Stiefel to acquire psoriasis, eczema compound from Welichem | The psoriasis market is large and growing. Psoriasis products totaled $4.5 billion in 2011 sales led by Amgen‘s (NASDAQ:AMGN) Enbrel, according to Research and Markets. Psoriasis sales are projected to reach $5.5 billion by 2020. WBI-1001, ... |
| 21.05.2012 | GSK’s Stiefel loses $1.5M stock buyback verdict; SEC case still pending | “Our client is obviously overjoyed, but the outpouring of support from former employees has been dramatic,” Finnerty attorney Norman Segall told Bloomberg News. GSK is considering an appeal. “We are disappointed with the jury’s verdict, and... |
| 14.05.2012 | New acne treatment: GSK’s topical Fabior Foam gets FDA approval | Between 40 million and 50 million Americans struggle with acne, according to the American Academy of Dermatology. It’s hardly an underserved population, but it is a growing market. Research firm Global Industry Analysts projects that the gl... |
| 12.12.2011 | GSK subsidiary Stiefel Labs charged in $110M stock scheme | “Private companies and their officers must understand that they are not immune from the federal securities laws, which protect all shareholders regardless of whether they bought stock in the open market or earned shares through a company’s ... |
| 04.08.2009 | Freedom Meditech lands investments to develop diabetes medical devices | “We believe that this additional investment in the company is a vote of confidence in our innovative approach for painlessly and non-invasively measuring daily glucose levels from the eye,†Craig Misrach, president and CEO of Freedom Medi... |
| 26.10.2007 | Cratering VC funding for biotech: Still plenty bad, although not what it originally seemed | Are venture capitalists really shunning biotechnology, as I wrote a few days ago? A deeper look at the data suggests the answer is still yes, although not exactly for the reasons I first suspected. First off, the most striking data point I ... |
| 24.10.2006 | Stiefel Labs to buy skin biotech co., Connetics for $640M | Connetics, one of Silicon Valley’s biggest biotechnology companies, will be bought for $640 million by Stiefel Laboratories of Coral Gables, Fla., under a proposed deal announced Monday. See Mercury News story. If the sale is approved by sh... |
| - | New acne treatment: GSK’s topical Fabior Foam gets FDA approval | A new acne treatment from GlaxoSmithKline (NYSE:GSK) now has marketing approval in the United States to tackle pimples and blackheads in acne sufferers. Tazarotene, which will be marketed under the name Fabior Foam, is a topical foam develo... |
| - | Freedom Meditech secures $2M as it awaits approval of chronic disease detection device | Diabetes device company Freedom Meditech has secured a $2 million line of credit from the Silicon Valley Bank, some of which will be disbursed immediately with additional funds being released at certain milestones. The San Diego-based compa... |
Show more